TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31797721

Group type: EXPERIMENTAL
Intervention: GH replacement
Number of subjects: 18
Study: 29848962

Group type: EXPERIMENTAL
Intervention: Dried apples + rice (DApp + R)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Mixed meals (DF + R + A)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Dried fruits (DApp, DJ, Ra, DApr)
Number of subjects: 11
Study: 29175841

Group type: EXPERIMENTAL
Intervention: Littlewoods forceps
Number of subjects: 100

Group type: COMPARATOR
Intervention: Single-toothed tenaculum forceps
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both forceps
Number of subjects: 100
Study: 24744309

Group type: EXPERIMENTAL
Intervention: Low-AGE diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: High-AGE diet
Number of subjects: 24
Study: 22709418

Group type: EXPERIMENTAL
Intervention: Intracameral phenylephrine 1.5% (group 1)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Balanced saline solution (group 2)
Number of subjects: 42
Study: 19814625

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17686111

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray 110 microg
Number of subjects: 285

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 285
Study: 16327499

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LPS)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 517
Study: 11931674

Group type: COMPARATOR
Intervention: Social phobics during the social conversation task
Number of subjects: 54

Group type: COMPARATOR
Intervention: Clinically anxious group during the imagery task
Number of subjects: 54

Group type: COMPARATOR
Intervention: Both clinical groups during the social conversation task
Number of subjects: 54

Group type: COMPARATOR
Intervention: Both clinical groups during the imagery task
Number of subjects: 54
Study: 9814616

Group type: EXPERIMENTAL
Intervention: DCLHb 25 mg/kg
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: DCLHb 50 mg/kg
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: DCLHb 100 mg/kg
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 7659434

Group type: EXPERIMENTAL
Intervention: Significant-other version of the WHYMPI scales
Number of subjects: 0
Study: 2642329

Group type: EXPERIMENTAL
Intervention: Oral acyclovir (800 mg) daily, taken twice daily
Number of subjects: 261

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 261
Study: 135666

Group type: COMPARATOR
Intervention: Adriamycin alone (60 mg/m2 intravenously every 3 weeks)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Adriamycin plus streptozotocin (adriamycin 60 mg/m2 every 3 weeks + streptozotocin 500 mg/m2/day intravenously for 5 days every 3 weeks)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Adriamycin plus streptozotocin
Number of subjects: 31
Study: 31586368

Group type: EXPERIMENTAL
Intervention: Internet-based self-help program SaveMySkin (12-week program based on cognitive-behavioral therapy)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 133
Study: 29112155

Group type: EXPERIMENTAL
Intervention: Bee venom acupuncture (BVA)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 54
Study: 25705815

Group type: EXPERIMENTAL
Intervention: Follow-up telephone call by a senior orthopaedic nurse
Number of subjects: 219

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 219
Study: 22568471

Group type: EXPERIMENTAL
Intervention: 1 g of DHA supplementation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo soy oil
Number of subjects: 21
Study: 22012833

Group type: EXPERIMENTAL
Intervention: Dobutamine (2.5 μg/kg/min) administered postoperatively for 2 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pancreaticoduodenectomy group (C)
Number of subjects: 20
Study: 18176855

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 10
Study: 15944424

Group type: EXPERIMENTAL
Intervention: Endovascular repair
Number of subjects: 351

Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 351
Study: 12420901

Group type: EXPERIMENTAL
Intervention: Problem-solving treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antidepressant medication
Number of subjects: 0
Study: 10340237

Group type: EXPERIMENTAL
Intervention: Coping strategies
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Subjective representation of body image
Number of subjects: 43
Study: 8942509

Group type: EXPERIMENTAL
Intervention: M-cup vacuum extractor cup
Number of subjects: 637

Group type: COMPARATOR
Intervention: Obstetric forceps
Number of subjects: 637
Study: 2018732

Group type: EXPERIMENTAL
Intervention: Topical corticosteroid creams (four types representative of potency groups)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Base cream (control)
Number of subjects: 6
Study: 6605681

Group type: EXPERIMENTAL
Intervention: Fenbufen (1,000 mg a day)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Indomethacin (150 mg a day)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Naproxen (750 mg a day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31369520

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (target SBP 100< SBP ≤120 mmHg)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management
Number of subjects: 379

Group type: COMPARATOR
Intervention: Standard blood pressure management (target SBP 120< SBP ≤140 mmHg)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Standard blood pressure management
Number of subjects: 379
Study: 27573909

Group type: EXPERIMENTAL
Intervention: Acute psychosocial stress (Trier Social Stress Test, TSST)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control session (no stress)
Number of subjects: 85
Study: 25819196

Group type: EXPERIMENTAL
Intervention: Intravenous esmolol
Number of subjects: 412

Group type: COMPARATOR
Intervention: Intravenous metoprolol
Number of subjects: 412
Study: 24575769

Group type: EXPERIMENTAL
Intervention: TAP block with bupivacaine 0.25%
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo group with sterile saline solution
Number of subjects: 197
Study: 22971499

Group type: EXPERIMENTAL
Intervention: Target effect‐site remifentanil concentration of 1 ng/ml (R1 group)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Target effect‐site remifentanil concentration of 2 ng/ml (R2 group)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 102
Study: 19491611

Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire regarding awareness of HPV
Number of subjects: 23000

Group type: COMPARATOR
Intervention: Comparison with earlier study in Danish women
Number of subjects: 23000

Group type: EXPERIMENTAL
Intervention: Higher educational level and history of self-reported genital warts
Number of subjects: 23000

Group type: EXPERIMENTAL
Intervention: Condom use and excellent self-rated health
Number of subjects: 23000

Group type: EXPERIMENTAL
Intervention: Age, lifetime number of sexual partners, smoking and drinking patterns
Number of subjects: 23000
Study: 17330241

Group type: EXPERIMENTAL
Intervention: Local anaesthesia
Number of subjects: 616

Group type: COMPARATOR
Intervention: Regional anaesthesia
Number of subjects: 616

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 616
Study: 15371577

Group type: EXPERIMENTAL
Intervention: Prophylactic radiofrequency catheter ablation
Number of subjects: 60

Group type: COMPARATOR
Intervention: No ablation (control group)
Number of subjects: 60
Study: 11351147

Group type: EXPERIMENTAL
Intervention: Intraduodenal artificial bile infusion (80 mol% bile acids; 15 mol% phospholipids; 5 mol% cholesterol)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intraduodenal saline infusion (placebo)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intraduodenal artificial bile infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intraduodenal saline infusion
Number of subjects: 12
Study: 9859958

Group type: EXPERIMENTAL
Intervention: Chiron rgp 120 (SF-2) 15 or 50 microg; MicroGeneSys rgp 160 (IIIB) 40 or 320 microg; Genentech rgp120 (MN) 75 or 300 microg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant control (Alum or MF-59)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vaccine (various rgp vaccines)
Number of subjects: 0
Study: 7542831

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 2684920

Group type: EXPERIMENTAL
Intervention: Relaxation therapy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Relaxation and music therapy (combined)
Number of subjects: 80
Study: 1108622

Group type: EXPERIMENTAL
Intervention: Supplementary potassium (48 mEq)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 46
Study: 31835196

Group type: EXPERIMENTAL
Intervention: Self-distancing prompt (writing or video)
Number of subjects: 0
Study: 30612854

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 54
Study: 28375709

Group type: EXPERIMENTAL
Intervention: Hands-free abdominal compression device (ACD) - N-Doe Pillow™
Number of subjects: 150

Group type: COMPARATOR
Intervention: Manual pressure (Control)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Hands-free abdominal compression device (ACD)
Number of subjects: 150
Study: 24830423

Group type: COMPARATOR
Intervention: 0.9% saline (Group A)
Number of subjects: 92

Group type: COMPARATOR
Intervention: 0.45% saline (Group B)
Number of subjects: 92

Group type: COMPARATOR
Intervention: 0.18% saline (Group C)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Hypotonic saline (Group B and C combined)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Isotonic saline (Group A)
Number of subjects: 92
Study: 23838870

Group type: EXPERIMENTAL
Intervention: 2-L polyethylene glycol electrolyte solution enriched in vitamin C
Number of subjects: 188

Group type: COMPARATOR
Intervention: 4-L polyethylene glycol electrolyte solution
Number of subjects: 188
Study: 21966835

Group type: EXPERIMENTAL
Intervention: American Diabetes Association 75 g curve
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: American Diabetes Association 100 g curve
Number of subjects: 87

Group type: COMPARATOR
Intervention: World Health Organization 75 g curve
Number of subjects: 87
Study: 19903918

Group type: EXPERIMENTAL
Intervention: Prone positioning (20 hours per day)
Number of subjects: 342
Study: 16616406

Group type: EXPERIMENTAL
Intervention: Enhanced social support services
Number of subjects: 200

Group type: COMPARATOR
Intervention: Support group (control)
Number of subjects: 200
Study: 15579530

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) 2 g/kg monthly for 4 months
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Intravenous immunoglobulin (IVIG) and Placebo
Number of subjects: 101
Study: 11520521

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 2658

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2658
Study: 9421325

Group type: EXPERIMENTAL
Intervention: Teicoplanin plus tobramycin
Number of subjects: 68

Group type: COMPARATOR
Intervention: Cephalothin plus tobramycin
Number of subjects: 68
Study: 8489059

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil 10 micrograms
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil 10 micrograms with 0.2 mg epinephrine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (Intrathecal sufentanil without epinephrine)
Number of subjects: 40
Study: 3337409

Group type: EXPERIMENTAL
Intervention: Weighted radiographs
Number of subjects: 83

Group type: COMPARATOR
Intervention: Plain (unweighted) radiographs
Number of subjects: 83
Study: 31562147

Group type: EXPERIMENTAL
Intervention: Edible taste film kit test
Number of subjects: 62

Group type: COMPARATOR
Intervention: Taste solution test
Number of subjects: 62
Study: 28509078

Group type: EXPERIMENTAL
Intervention: Vitamin D (50,000 IU/week)
Number of subjects: 80
Study: 25451430

Group type: EXPERIMENTAL
Intervention: Ketamine infusion (0.5 mg/kg)
Number of subjects: 29
Study: 23385548

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA) with piritramid intravenously by infusion pump
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard pain management with oral non-steroidal analgesics
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA)
Number of subjects: 38
Study: 20850348

Group type: EXPERIMENTAL
Intervention: Propofol infusion beginning at 25 μg/kg/min and morphine boluses (P)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Fentanyl infusion beginning at 2 μg/kg/h and midazolam boluses (F)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Propofol and fentanyl infusions beginning at 25 μg/kg/min and 0.5 μg/kg/h (PF)
Number of subjects: 145
Study: 18166166

Group type: EXPERIMENTAL
Intervention: Intermediate spatial frequency (SF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High spatial frequency (SF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upright faces
Number of subjects: 0
Study: 22015327

Group type: COMPARATOR
Intervention: Oral contraceptive (OC) alone (ethinyl estradiol [EE] 0.035 mg + norethindrone [NET] 1 mg)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: OC + vicriviroc
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: OC + ritonavir
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: OC + vicriviroc + ritonavir
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo OC
Number of subjects: 27

Group type: COMPARATOR
Intervention: OC alone
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: vicriviroc + OC
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: ritonavir + OC
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: vicriviroc + ritonavir + OC
Number of subjects: 27

Group type: COMPARATOR
Intervention: placebo OC
Number of subjects: 27
Study: 16105178

Group type: EXPERIMENTAL
Intervention: Applications with at least one error
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Applications excluding 'benign' errors
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Publications in applications
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Claims of advanced degrees
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Inter-rater reliability of evaluations
Number of subjects: 493
Study: 11876511

Group type: EXPERIMENTAL
Intervention: bezafibrate (400 mg once daily)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: gemfibrozil (600 mg twice daily)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: fenofibrate (200 mg once daily)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: fibrates (general)
Number of subjects: 69
Study: 9842605

Group type: EXPERIMENTAL
Intervention: 12-min. run
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 1.5 mile run
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 20-m progressive shuttle run
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: treadmill jogging test
Number of subjects: 32
Study: 7813537

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg, 0.4 g/kg body weight per day for 5 consecutive days, followed by the same dose once every 2 weeks for 3 months)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg)
Number of subjects: 15
Study: 2776469

Group type: EXPERIMENTAL
Intervention: 100 mg flurbiprofen twice daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: 500 mg diflunisal twice daily
Number of subjects: 50
Study: 791433

Group type: EXPERIMENTAL
Intervention: Bilateral ECT
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dominant/Nondominant Unilateral ECT
Number of subjects: 20
Study: 31651593

Group type: EXPERIMENTAL
Intervention: Office-based vergence/accommodative therapy
Number of subjects: 311

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 311
Study: 29952617

Group type: EXPERIMENTAL
Intervention: Positively framed message about peers who do use PBS
Number of subjects: 89

Group type: COMPARATOR
Intervention: Negatively framed message about peers who do not use PBS
Number of subjects: 89
Study: 27129980

Group type: EXPERIMENTAL
Intervention: Nurse-based telephone follow-up
Number of subjects: 201

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 201
Study: 25207898

Group type: EXPERIMENTAL
Intervention: Sodium cantharidinate/vitamin B6 + GP regimen (30 ml cantharidinate/vitamin B6 for four 21-day cycles)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Regular GP regimen (for four 21-day cycles)
Number of subjects: 86
Study: 22136317

Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg/day)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Tamoxifen (20 mg/day)
Number of subjects: 97
Study: 20638919

Group type: EXPERIMENTAL
Intervention: Internet-based prevention program, Trouble on the Tightrope: In Search of Skateboard Sam
Number of subjects: 190

Group type: COMPARATOR
Intervention: Attention placebo control condition
Number of subjects: 190
Study: 17620970

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 60 mg once daily
Number of subjects: 7665

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7665
Study: 15285036

Group type: EXPERIMENTAL
Intervention: Intravenous bolus injection of regular insulin (20 U) followed by glucose infusion (500 mL 50 g/L dextrose)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intravenous bolus injection of regular insulin (20 U)
Number of subjects: 16
Study: 11594976

Group type: EXPERIMENTAL
Intervention: WHO criteria for blindness (best-corrected visual acuity worse than 0.05)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: National criteria for blindness (best-corrected visual acuity of 0.1 or worse)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Age-related macular degeneration (AMD)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Glaucoma, myopic macular degeneration, cataract, retinitis pigmentosa
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Amblyopia
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Diabetic retinopathy
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1000
Study: 9597405

Group type: EXPERIMENTAL
Intervention: Dalteparin (a low molecular weight heparin)
Number of subjects: 256
Study: 8270968

Group type: EXPERIMENTAL
Intervention: Bone marrow transplantation (BMT)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Chemotherapy maintenance regimens (continuous vs cyclic)
Number of subjects: 490
Study: 2643934

Group type: EXPERIMENTAL
Intervention: Intravenous clonidine (2 micrograms/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Oral clonidine (flexible-dose treatment for averaging ten weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 4613812

Group type: EXPERIMENTAL
Intervention: Phototherapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no phototherapy)
Number of subjects: 24
Study: 30454014

Group type: COMPARATOR
Intervention: Conventional neurorehabilitation (control)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Novel self-management intervention (8 sessions of 45-60 min by physiotherapist or occupational therapist over 9 months)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 70
Study: 28844358

Group type: EXPERIMENTAL
Intervention: Routine inquiry about violence victimization
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Routine inquiry about alcohol consumption
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Talking about violence
Number of subjects: 15
Study: 25542267

Group type: EXPERIMENTAL
Intervention: Onartuzumab with weekly paclitaxel
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control (placebo plus bevacizumab plus paclitaxel)
Number of subjects: 185
Study: 23855167

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 4% calcium hydroxide
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 4% Dimethyl Sulfoxide (DMSO) extract of propolis
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 60
Study: 20861645

Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus L-92
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard medical therapy (topical application of a steroid ointment)
Number of subjects: 0
Study: 18502235

Group type: EXPERIMENTAL
Intervention: Chickpeas (728 g/week for 12 weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Usual diet (without chickpeas for 4 weeks)
Number of subjects: 45
Study: 16979407

Group type: EXPERIMENTAL
Intervention: Exercise training (aerobic exercise 3 to 4 days per week for 6 months at 70% to 85% maximal heart rate for 45 to 60 minutes per session)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Exercise training and Control group (AA women)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (CA women)
Number of subjects: 47
Study: 12171084

Group type: EXPERIMENTAL
Intervention: CABLES model
Number of subjects: 0
Study: 10511348

Group type: EXPERIMENTAL
Intervention: Transdermal E2-norethindrone acetate (50-140 microg/day)
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Transdermal E2-norethindrone acetate (50-250 microg/day)
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Transdermal E2-norethindrone acetate (50-400 microg/day)
Number of subjects: 625

Group type: COMPARATOR
Intervention: Transdermal E2 (50 microg/day)
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Transdermal E2-norethindrone acetate
Number of subjects: 625
Study: 7747857

Group type: EXPERIMENTAL
Intervention: Intranasal midazolam 0.2 mg.kg‐1
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.5 mg.kg‐1
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Rectal midazolam 0.3 mg.kg‐1
Number of subjects: 3